A few people, including one of the members of our Scientific Advisory Board, have asked us, ‘How do you finance The “New” Prostate Cancer InfoLink?’
The services made available through Prostate Cancer International, Inc. are largely a “labor of love.” And to the greatest possible extent we intend to make sure they stay that way:
- We have no paid staff.
- We have minimal out of pocket expenses (for things like travel).
- The software used to run our web sites is pretty much free.
- We have made an absolute commitment not to seek funding from any pharmaceutical, biotechnology, or medical device company.
- The only other cost identified to date over which we have no control is a certain amount of insomnia!
Having said that, we do accept small amounts of unsolicited funding from commercial organizations with an interest in prostate cancer, so long as those funds are unrestricted in nature.
At this time, Prostate Cancer International is the recipient of a grant of $10,000 offered by Medivation, Inc. and Astellas Pharma, Inc. (the co-developers of a drug currently known as MDV3100). These funds are being used primarily to cover travel and other related costs associated with attendance at major meetings during 2011.